Investigating the role of a stress response protein in age-related vision loss

Unifying Mechanism of Oxidative Stress and Inflammation in AMD

NIH-funded research Pennsylvania State Univ Hershey Med Ctr · NIH-11003728

This study is looking at how a protein called REDD1 might play a role in age-related macular degeneration (AMD), a common cause of vision loss, to help find new ways to treat and improve vision for people with this condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr NIH-funded
Lab location1 site (Hershey, United States)
Project IDNIH-11003728 on NIH RePORTER

What this research studies

This research focuses on understanding how a specific protein, REDD1, contributes to age-related macular degeneration (AMD), a leading cause of vision loss. The study will explore how REDD1 affects the retinal pigment epithelium's response to stress and inflammation as people age. Using advanced mouse models and human cells, researchers aim to uncover the molecular mechanisms behind AMD and assess potential therapeutic strategies. The findings could lead to new treatments that improve visual function in patients with AMD.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults experiencing early signs of age-related macular degeneration.

Not a fit: Patients with other forms of vision loss unrelated to age-related macular degeneration may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies that enhance vision and slow the progression of age-related macular degeneration.

How similar studies have performed: Previous studies have shown promise in targeting REDD1 for improving visual function in AMD, indicating a potential for success in this approach.

Where this research is happening

Hershey, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions age related macular disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.